Selective tyrosine kinase inhibitors

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.5, Iss.3, 2000-10, pp. : 287-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design of Selective Inhibitors of Tyrosine Kinase 2

Letters in Drug Design & Discovery, Vol. 2, Iss. 7, 2005-11 ,pp. : 507-515

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Design of Potent and Selective EGFR Tyrosine Kinase Inhibitors as Anticancer Agents

Current Cancer Drug Targets, Vol. 1, Iss. 2, 2001-08 ,pp. : 129-140

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors

Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. : 462-483

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular toxicity of tyrosine kinase inhibitors

By Mouhayar Elie Durand Jean-Bernard Cortes Jorge

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 687-696

Informa Healthcare

Access to resources Recommend Favorite

Effects of inhibitors for tyrosine kinase and non-selective cation channel on capacitative Ca 2+ entry in rat ileal smooth muscle

By Ohta T. Yasuda W. Hasegawa A. Ito S. Nakazato Y.

European Journal of Pharmacology, Vol. 387, Iss. 2, 2000-01 ,pp. : 211-220

Elsevier

Access to resources Recommend Favorite